On Wednesday, 14 October, health authorities recorded a second laboratory-confirmed Ebola infection in Kenya — a 39-year-old person with a family connection to the initial patient, who had already been placed under quarantine. Health authorities confirmed the two cases share a common source, with no indication that the infection has spread into the broader population.
A 21-day quarantine period for close contacts of the first confirmed case had been placed on the second patient before any symptoms appeared, owing to a close family connection with the first confirmed case. Symptoms of fever, fatigue, and joint pain were noted on Tuesday, 13 October, according to the ministry's statement.
Testing at two separate facilities — the National Virology Reference Laboratory and the KEMRI-CDC laboratory — yielded a positive outcome at each site. KEMRI, the Kenya Medical Research Institute, was founded by the Kenyan government as a dedicated medical research body and operates that laboratory in partnership with the US Centers for Disease Control and Prevention.
The second patient is receiving supportive medical attention at a designated treatment facility. The health ministry withheld both the name of the treatment facility and details about the patient's condition, while Director General Patrick Amoth told reporters on Wednesday that Kenya's total stood at two laboratory-confirmed cases alongside one fatality.
According to Dr. Amoth, the two cases share a direct link, and no indication of broader community transmission has been found. Of the 128 individuals flagged as having had contact with the first patient, 113 have since been located by ministry staff. Within that group, 108 remain under a 21-day quarantine period on Kenyan soil, while the remaining five are located abroad.
The individual who became the index case was born in Kenya and had spent seven years living in the Democratic Republic of the Congo before the illness was identified. Falling ill at that location, he travelled overland through Uganda's capital before arriving in Nairobi on Saturday, 3 October. Confirmation of the Bundibugyo strain of Ebola — established through testing conducted at both national laboratories and KEMRI sites — preceded the death, which took place at Nairobi Hospital, a privately operated facility in the capital. A disclosure about the initial confirmed case came from Health Cabinet Secretary Aden Duale.
Wessam Mankoula, who leads emergency preparedness at Africa CDC, told a broadcast outlet on Wednesday that Kenya's contact-tracing efforts are outpacing those recorded in Congo. Africa CDC, the public health arm of the African Union with its headquarters in Addis Ababa, traces at least 60 contacts for every confirmed Ebola case, Mankoula noted. Inadequate contact-tracing efforts, he indicated, leave the door open for the virus to persist in circulation over an extended period — a concern he underscored by reference to the ongoing situation in Congo.
Genetically, the Bundibugyo strain stands apart from the Zaire variant that drove the West African outbreak spanning 2014 through 2016. No vaccines or targeted therapies have been cleared for use against Bundibugyo virus disease, the CDC has noted. Supportive treatment delivered at an early stage forms the foundation of the clinical approach, and that is the path the patient in Kenya is currently on.
The ministry advised people showing any symptoms resembling those of Ebola to consult a healthcare provider promptly, and called on the public to remain composed. Three contact options were put in place for Ebola-related calls and messages: the 719 hotline, a short code, and a dedicated WhatsApp line.
As of 15 October, Kenya carried no Ebola-related travel notice on the CDC's published listings. Travel advisories issued by the CDC for Ebola list the Democratic Republic of the Congo and Uganda as affected destinations. Four provinces in Congo fall under the advisory's scope — Ituri and Nord-Kivu drawing a full do-not-travel designation, while Haut-Uélé and Tshopo carry a recommendation to avoid trips deemed nonessential.
People who visited Congo in the past 21 days are barred from boarding commercial aircraft headed to the United States under a temporary travel measure. Those travelling from Uganda or South Sudan — but not from Congo — are required to arrive via specific airports where additional health checks are carried out, provided they hold American citizenship. Nairobi falls outside the scope of those restrictions, meaning a transit through the Kenyan capital carries no exposure to the American measures under the rules in place as of Thursday.
No details have emerged from the ministry about the location where the second patient is receiving care, nor about the approach planned for reaching the 15 contacts who remain unaccounted for. No disclosure has been made regarding which countries are hosting the five overseas contacts. Questions about the number of people the second patient encountered before going into isolation — and whether any of those individuals now face a fresh monitoring window — have yet to be answered. No timeline has been set by authorities for when Kenya might be declared free of Ebola.
